Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
This piece highlights why new investors favor index funds, emphasizing simplicity, cost efficiency, and dependable long-term results.
21,776 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
The BEA reports the U.S. economy expanded at a 1.4% annualized rate in Q4, far below economists' 3% projection. The s...
When life tests a family, money becomes a shared tool. This article draws on the idea behind john stamos says family ...
NVIDIA doubles down on its OpenAI investment strategy to secure GPU demand and influence the AI software stack, a mov...
A potential $67 billion move between nextera energy and duke energy could redefine how regulated utilities grow, fund...
A Utah mother of three stands trial for murder after a year of tragedy, with prosecutors alleging a fentanyl-linked d...
In 2026, equal-weight XSD and cap-weight SMH offer contrasting bets on AI-driven chipmakers. This article analyzes ho...
Washington asserts that existing tariff pacts stay in force even after a Supreme Court setback. The stance draws mixe...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
A new moisture-absorbing paint-and-primer system backed by large homebuilders is entering the market, promising to re...
A retiree who kept spouse’s employer plan past 65 faced a Medicare late enrollment penalty after his wife retired. Th...
Paramount Global and Skydance are stepping up with a bigger offer for Warner Bros. Discovery, aiming to outpace Netfl...